Smallpox
Overview
Causative Agent
- Variola virus, a species of Orthopoxvirus
Incubation Period
- 12-14 days (range 7-17 days)
Infectious Period
- From fever onset (usually 2–4 days before rash) until last scab has separated; about three weeks.
Transmission
- Aerosols/droplets from nasopharyngeal lesions and contact with contaminated articles.
Epidemiology
- Last naturally acquired human case in the world occurred in Somalia in 1977; global eradication was certified two years later.
There are at least 2 strains, variola major and the variola minor.
- Variola major: the more severe form with case fatality rate up to 30-50% in susceptible populations.
- Variola minor: milder form of the disease with more diminutive pox lesions; case fatality rate of 1-2% in susceptible populations.
Signs & Symptoms
Clinical Features
- Characteristic rash appears 2-4 days after non-specific, flu-like prodrome (fever and headache).
- Maculopapular rash begins on mucosa of mouth and pharynx, face, hands, forearms and spreads to legs and centrally to trunk; lesions are more predominant on the face and extremities than on the trunk (centrifugal).
- Lesions progress synchronously on any given part of the body from macules to papules to vesicles to pustules and to crusty scabs.
Two rare forms of invariably fatal smallpox have been reported:
- Purpura variolosa or hemorrhagic type smallpox
- Flat type smallpox
Differential diagnosis
- Chickenpox, monkeypox, disseminated herpes zoster.
Clues to distinguish smallpox from chickenpox:
- Smallpox lesions are synchronous in their stage of development.
- Smallpox has many more lesions on the face and extremities than trunk (centrifugal spread)
- Smallpox lesions are more common on palms and soles
- Smallpox lesions are more deeply imbedded in the dermis compared with the superficial lesions of chickenpox
Detection & Treatment
- Electron microscopy, PCR, viral isolation (culture of pharyngeal swab or lesions).
- Guarnieri bodies on Giemsa or modified silver stain.
Care Management
- Supportive care.
- Antibiotics may be used for secondary bacterial infection.
- Vaccination within 3 days of exposure may significantly ameliorate or prevent smallpox. Vaccination 4 to 7 days after exposure likely still offers some protection or modification of disease severity.
- Notify MOH immediately on suspicion. Call MOH Communicable Diseases Surveillance team at: 98171463
- Airborne and contact precautions. Isolate patients in negative pressure isolation room.
- Patients should be considered infectious until all scabs separate and should be isolated during this period.
- Droplet and airborne precaution for a minimum of 17 days following exposure for all persons in direct contact with the index case.
References
- Henderson DA, Inglesby TV et al. Smallpox as a biological weapon: medical and public health management. Working group on Civilian Biodefense. JAMA 1999; 281: 2127-37
- Committee on Epidemic Diseases. Clinical guidelines on anthrax, botulism, plague and smallpox. Epidemiological News Bulletin. 2001; 27:61-68
- CDC (Atlanta), Smallpox overview. 2004. Available from http://emergency.cdc.gov/agent/smallpox/overview/disease-facts.asp. Accessed Dec 2010.
- WHO. Smallpox. 2010. Available from http://www.who.int/mediacentre/factsheets/smallpox/en. Accessed Dec 2010.

